Key Highlights

  • AAON climbed 27.03% to USD 79.86 after third-quarter net sales leapt 84.1% to USD 707.4 million and the 2026 sales growth outlook was lifted to 72% to 75% from 55% to 60%.
  • Estrella Immunopharma advanced 26.48% to USD 0.6500 and ATA Creativity Global added 21.33% to USD 0.7098, both with no catalyst identified in published coverage and both under USD 1.00.
  • Senseonics gained 26.12% to USD 12.36 on 2.12 million shares, 2.70 times normal volume, after lifting 2026 Revenue guidance to USD 68 million to USD 70 million.
  • Cheche Group gained 23.30% to USD 11.80 on only 20.41 thousand shares, so thin trading and a January 11, 2027 Nasdaq compliance deadline shape the risk.

AAON (NASDAQ:AAON): Up 27.03% on Third-Quarter Results and a Raised Outlook

AAON (NASDAQ:AAON) closed at USD 79.86, up 27.03% from a calculated prior close of USD 62.87, following a November 9 release for the quarter ended September 30. Net sales grew 84.1% to USD 707.4 million, diluted EPS was USD 0.83 versus USD 0.37, and the 2026 sales growth outlook moved up to 72% to 75% from 55% to 60%. As general context, a better outlook lifts estimates and can trigger a re-rating. Backlog of USD 1,854.5 million was 5.9% lower than the USD 1,960.3 million at June 30, and the company restated the first two quarters of 2026. The snapshot lists a Market Value of USD 6.59 billion, a P/E of 41.78 and Volume of 1.56 million shares at a relative volume of 0.97. Revolver Debt was USD 386.7 million against USD 3.7 million of cash. Shares of AAON (NASDAQ:AAON) still sit about 46.9% under the 52-week high of USD 150.46 (calculated), and a gap of this size can reverse.

Estrella Immunopharma (NASDAQ:ESLA): Up 26.48% With No Identified Catalyst

Estrella Immunopharma (NASDAQ:ESLA) closed at USD 0.6500, up 26.48% from a calculated prior close of USD 0.5139, and published coverage dated November 9 or 10, 2026 identified no catalyst. Two searches turned up no results, trial data, financing, listing notice or analyst action. As general context, sub-dollar biotech shares can leap on a low float, Social Media attention, sector rotation or short covering without any company news. The company develops T-cell therapies at the pre-clinical stage, and its trailing loss of USD 0.25 per share equals about 38.5% of the share price (calculated). Market value is USD 28.27 million, about 43.5 million shares (calculated), and volume was 1.49 million shares at a relative volume of 1.53. The 52-week range ran from USD 0.295 to USD 3.15. A few trades can move the price, and dilution is a recurring risk. Estrella Immunopharma (NASDAQ:ESLA) could reverse, and nothing here suggests the move will continue.

Senseonics (NASDAQ:SENS): Up 26.12% on Third-Quarter Results and Raised Guidance

Senseonics (NASDAQ:SENS) closed at USD 12.36, up 26.12% from a calculated prior close of USD 9.80, following a November 9 release. Third-quarter revenue was USD 19.6 million versus USD 8.1 million, gross Margin was near 62% versus 43%, and 2026 revenue guidance moved up to USD 68 million to USD 70 million from USD 62 million to USD 66 million. As general context, higher guidance resets analyst models and can draw buyers. The net loss grew to USD 32.7 million, or USD 0.50 per share, from USD 19.5 million. Volume was 2.12 million shares at a relative volume of 2.70. The snapshot lists a market value of USD 653.52 million and trailing EPS of USD -2.28, while the share count in the release implies about USD 677.0 million (calculated), so the share basis differs. Cash and short-term investments were USD 126.6 million against USD 55.0 million of debt. Senseonics (NASDAQ:SENS) may need financing, and the gain can reverse.

Cheche Group (NASDAQ:CCG): Up 23.30% With No Identified Catalyst

Cheche Group (NASDAQ:CCG) closed at USD 11.80, up 23.30% from a calculated prior close of USD 9.57, and published coverage dated November 9 or 10, 2026 identified no catalyst. Volume was only 20.41 thousand shares at a relative volume of 1.04, about USD 240.8 thousand traded (calculated). The newest company item found is a Nasdaq notice dated July 14, 2026 that stretched the bid price compliance period by 180 days to January 11, 2027. A price of USD 11.80 is far above the USD 1.00 minimum, which hints at a share consolidation or a change of share basis that was not confirmed. As general context, small-cap rebounds often come with thin order books and short covering. Market value is USD 29.56 million, about 2.51 million shares (calculated), and trailing EPS is USD -2.25. A few trades can move Cheche Group (NASDAQ:CCG), and nothing here suggests the move will continue.

ATA Creativity Global (NASDAQ:AACG): Up 21.33% With No Identified Catalyst

ATA Creativity Global (NASDAQ:AACG) closed at USD 0.7098, up 21.33% from a calculated prior close of USD 0.5850, and published coverage dated November 9 or 10, 2026 identified no catalyst. Volume was 6.48 million shares at a relative volume of 593.06, which implies a recent average near 10,926 shares (calculated) and about USD 4.60 million traded. Earlier items include a notice of a June 5, 2026 meeting on selling ATA BVI and a 69.0417% stake in Huanqiuyimeng for RMB 1, alongside a private Placement of 45,306,792 shares, with outcomes not confirmed. As general context, a volume spike of this size in a security under USD 1.00 often reflects a small float or speculative flows. Market value is USD 25.17 million, about 35.46 million shares (calculated). The price sits 29.0% under the USD 1.00 Nasdaq bid level, and ATA Creativity Global (NASDAQ:AACG) can reverse quickly.

Where Things Stand

The largest further gainer on November 10, 2026 was AAON (NASDAQ:AAON), up 27.03% on results and a raised outlook. The only thing linking the five names is the size of the move: two had results, two had no catalyst identified and one had thin trading under a listing deadline. For Canadian investors following US-listed stocks, large one-day gains in thinly traded names can reverse in the next session because a few trades set the price and spreads can be wide. The rankings rest on a published screener snapshot of the November 10, 2026 regular session, and some figures are calculated.